Escuriola Ettingshausen C - Search Results

1

A review of immune tolerance induction with Haemate P in haemophilia A.

Escuriola Ettingshausen C, Kreuz W. Escuriola Ettingshausen C, et al. Haemophilia. 2014 May;20(3):333-9. doi: 10.1111/hae.12288. Epub 2013 Oct 24. Haemophilia. 2014. PMID: 24165472 Free article. Review.

2

Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.

Kreuz W, Becker S, Lenz E, Martinez-Saguer I, Escuriola-Ettingshausen C, Funk M, Ehrenforth S, Auerswald G, Kornhuber B. Kreuz W, et al. Among authors: escuriola ettingshausen c. Semin Thromb Hemost. 1995;21(4):382-9. doi: 10.1055/s-2007-1000659. Semin Thromb Hemost. 1995. PMID: 8747701

3

Epidemiology of inhibitors in haemophilia A.

Kreuz W, Escuriola-Ettingshausen C, Martinez-Saguer I, Güngör T, Kornhuber B. Kreuz W, et al. Among authors: escuriola ettingshausen c. Vox Sang. 1996;70 Suppl 1:2-8. Vox Sang. 1996. PMID: 8869461

4

Protein-C concentrate for meningococcal purpura fulminans.

Kreuz W, Veldman A, Escuriola-Ettingshausen C, Schneider W, Beeg T. Kreuz W, et al. Among authors: escuriola ettingshausen c. Lancet. 1998 Mar 28;351(9107):986-7; author reply 988. doi: 10.1016/S0140-6736(05)60653-8. Lancet. 1998. PMID: 9734967 No abstract available.

5

Radiological and orthopedic score in pediatric hemophilic patients with early and late prophylaxis.

Funk M, Schmidt H, Escuriola-Ettingshausen C, Pons S, Dzinaj T, Weimer C, Kornhuber B, Kreuz W. Funk M, et al. Among authors: escuriola ettingshausen c. Ann Hematol. 1998 Oct;77(4):171-4. doi: 10.1007/s002770050436. Ann Hematol. 1998. PMID: 9829849 Clinical Trial.

6

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.

Kreuz W, Escuriola-Ettingshausen C, Funk M, Schmidt H, Kornhuber B. Kreuz W, et al. Among authors: escuriola ettingshausen c. Haemophilia. 1998 Jul;4(4):413-7. doi: 10.1046/j.1365-2516.1998.440413.x. Haemophilia. 1998. PMID: 9873763

7

[Prevention of joint damage in hemophilic children with early prophylaxis].

Kreuz W, Escuriola Ettingshausen C, Funk M, Pons S, Schmidt H, Kornhuber B. Kreuz W, et al. Among authors: escuriola ettingshausen c. Orthopade. 1999 Apr;28(4):341-6. doi: 10.1007/PL00003616. Orthopade. 1999. PMID: 10335528 Clinical Trial. German.

8

Epidemiology of inhibitor development in haemophilia A patients treated with virus-inactivated plasma-derived clotting factor concentrates.

Kreuz W, Escuriola-Ettingshausen C, Martinez-Saguer I, Kaiml M, Kornhuber B. Kreuz W, et al. Among authors: escuriola ettingshausen c. Vox Sang. 1999;77 Suppl 1:3-8. doi: 10.1159/000056704. Vox Sang. 1999. PMID: 10529676 Review. No abstract available.

9

Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors.

Escuriola Ettingshausen C, Halimeh S, Kurnik K, Schobess R, Wermes C, Junker R, Kreuz W, Pollmann H, Nowak-Göttl U. Escuriola Ettingshausen C, et al. Thromb Haemost. 2001 Feb;85(2):218-20. Thromb Haemost. 2001. PMID: 11246535

10

Inhibitor treatment by rituximab in congenital haemophilia A - Two case reports.

Streif W, Escuriola Ettingshausen C, Linde R, Kropshofer G, Zimmerhackl LB, Kreuz W. Streif W, et al. Among authors: escuriola ettingshausen c. Hamostaseologie. 2009 May;29(2):151-4. Hamostaseologie. 2009. PMID: 19404522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page